| C09AA05 |
Ramipril |
Ramigamma |
Tablet |
10 |
mg |
30 |
Woerwag Pharma GmbH & Co.KG, Германия |
2.5 |
mg |
- |
8.17 |
0.033 |
3.96 |
25% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 106/ 23.09.10; НСР-32/03.06.2013; НСР-7115/15.09.2015; НСР-11214/15.12.2016; НСР-15010/08.02.2018; НСР-18585/25.04.2019 |
02.06.2019 |
08.09.2012 |
|
Заличен |
1903 |
| C09AA05 |
Ramipril |
Ramigamma |
Tablet |
5 |
mg |
30 |
Woerwag Pharma GmbH & Co.KG, Германия |
2.5 |
mg |
- |
4.98 |
0.033 |
1.98 |
25% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 106/ 23.09.10.; НСР-7011/25.08.2015.; НСР-11083/01.12.2016;; НСР-12090/21.03.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
854 |
| C09AA05 |
Ramipril |
RamiHexal |
Tablet |
2.5 |
mg |
30 |
Hexal AG, Германия |
2.5 |
mg |
- |
2.89 |
0.033 |
0.99 |
25% |
0.24 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-684/30.05.2012 г.; КЦРР-2279/20.02.2013 г.; НСР-6134/29.04.2015; НСР-16028/29.06.2018; НСР-20963/05.03.2020;; НСР-21073/30.03.2020 Предварително изпълнение |
02.07.2020 |
08.09.2012 |
|
Заличен |
3886 |
| C09AA05 |
Ramipril |
RamiHexal |
Tablet |
2.5 |
mg |
30 |
Hexal AG, Германия |
2.5 |
mg |
- |
2.89 |
0.033 |
0.99 |
25% |
0.24 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-684/30.05.2012 г.; КЦРР-2279/20.02.2013 г.; НСР-6134/29.04.2015; НСР-16028/29.06.2018; НСР-20963/05.03.2020; НСР-21073/30.03.2020 Предварително изпълнение |
02.04.2020 |
08.09.2012 |
|
Заличен |
3886 |
| C09AA05 |
Ramipril |
RamiHexal |
Tablet |
5 |
mg |
30 |
Hexal AG, Германия |
2.5 |
mg |
- |
4.27 |
0.033 |
1.98 |
25% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-684/30.05.2012 г.; КЦРР-2278/20.02.2013 г.; КП-202/30.04.2015 и НСР-2127/14.12.2013; АССГ № 3120/09.05.2016 и КЦРР-2278/20.02.2013; КП-53/25.06.2018 и НСР-15160/02.03.2018 |
02.08.2018 |
08.09.2012 |
|
Активен |
3885 |
| C09AA05 |
Ramipril |
Ramimed |
Tablet |
10 |
mg |
30 |
Medochemie Ltd., Кипър |
2.5 |
mg |
- |
6.58 |
0.033 |
3.96 |
25% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 190/ 22.08.2011; КЦРР-1902/15.12.2012 г; НСР-1295/03.10.2013; НСР-4029/03.07.2014; НСР-10428/29.09.2016; НСР-17518/13.12.2018; НСР-20700/24.01.2020 |
02.03.2020 |
08.09.2012 |
|
Заличен |
3027 |
| C09AA05 |
Ramipril |
Ramimed |
Tablet |
5 |
mg |
30 |
Medochemie Ltd., Кипър |
2.5 |
mg |
- |
3.36 |
0.033 |
1.98 |
25% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-4726/26.09.2014; КП-18/15.02.2016 и НСР-7686/10.12.2015; КП-4/17.02.2017 и НСР-4726/26.09.2014; НСР-17517/13.12.2018; НСР-20834/13.02.2020 |
02.03.2020 |
|
|
Заличен |
3171 |
| C09AA05 |
Ramipril |
Ramimed |
Tablet |
5 |
mg |
30 |
Medochemie Ltd., Кипър |
2.5 |
mg |
- |
6.55 |
0.05417 |
3.25 |
25% |
0.81 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-683/30.05.2012 г.; НСР-1295/03.10.2013; НСР-3466/16.05.2014 |
16.06.2014 |
|
|
Заличен |
3171 |
| C09AA05 |
Ramipril |
Ramimed |
Tablet |
5 |
mg |
14 |
Medochemie Ltd., Кипър |
2.5 |
mg |
- |
2.32 |
0.033 |
0.92 |
25% |
0.23 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-19563/21.08.2019 |
02.10.2019 |
|
|
Активен |
16671 |
| C09AA05 |
Ramipril |
Ramimed |
Tablet |
10 |
mg |
14 |
Medochemie Ltd., Кипър |
2.5 |
mg |
- |
4.97 |
0.033 |
1.85 |
25% |
0.46 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-19563/21.08.2019 |
02.10.2019 |
|
|
Активен |
16672 |
| C09AA05 |
Ramipril |
Ramipril Teva |
Tablet |
5 |
mg |
30 |
Teva B.V., Нидерландия |
2.5 |
mg |
- |
8.94 |
0.033 |
1.98 |
25% |
0.49 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦPP-367/21,03,2012; НСР-639/29.07.2013; НСР-3203/07.04.2014; НСР-17418/06.12.2018; НСР-19254/18.07.2019 |
02.09.2019 |
08.09.2012 |
|
Активен |
2665 |
| C09AA05 |
Ramipril |
Ramipril Teva |
Tablet |
10 |
mg |
30 |
Teva B.V., Нидерландия |
2.5 |
mg |
- |
8.94 |
0.033 |
3.96 |
25% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-1701/27.11.2012 г.; НСР-4311/05.08.2014; НСР-7310/29.10.2015; НСР-17417/06.12.2018; НСР-19255/18.07.2019 |
02.09.2019 |
|
|
Активен |
3119 |
| C09AA05 |
Ramipril |
Tritace |
Tablet |
5 |
mg |
30 |
Беста Мед ЕООД, България |
2,5 |
mg |
- |
7.09 |
0.033 |
1.98 |
25% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
паралелен внос НСР-20857/20.02.2020 |
02.04.2020 |
|
|
Активен |
16875 |
| C09AA05 |
Ramipril |
Tritace |
Tablet |
5 |
mg |
30 |
Санофи България ЕООД, България |
2.5 |
mg |
- |
7.09 |
0.033 |
1.98 |
25% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-7720/17.12.2015 |
02.06.2016 |
|
|
Активен |
4169 |
| C09AA05 |
Ramipril |
Tritace |
Tablet |
10 |
mg |
30 |
Санофи България ЕООД, България |
2.5 |
mg |
- |
15.19 |
0.033 |
3.96 |
25% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-7720/17.12.2015; НСР-18367/05.04.2019 |
02.05.2019 |
|
|
Активен |
4168 |
| C09AA05 |
Ramipril |
TRITACE 10 |
Tablet |
10 |
mg |
28 |
Санофи-Авентис България ЕООД, България |
2.5 |
mg |
- |
6.43 |
0.03608 |
4.04 |
25% |
1.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-886/28.06.2012 г.; HCР-246/24.06.2013; НСР-3129/26.03.2014; НСР-8314/26.02.2016 |
02.04.2016 |
08.09.2012 |
|
Заличен |
2664 |
| C09AA05 |
Ramipril |
TRITACE 5 |
Tablet |
5 |
mg |
28 |
Санофи-Авентис България ЕООД, България |
2.5 |
mg |
- |
4.67 |
0.03608 |
2.02 |
25% |
0.5 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-690/30.05.2012 г.; НСР-3043/21.03.2014; НСР-8313/26.02.2016 |
02.04.2016 |
08.09.2012 |
|
Заличен |
2663 |
| C09AA05 |
Ramipril |
Vivace |
Tablet |
10 |
mg |
30 |
Актавис EАД, България |
2.5 |
mg |
- |
8.94 |
0.033 |
3.96 |
25% |
0.99 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-2378/21.02.2013 г.; НСР-6214/21.05.2015; НСР-10178/31.08.2016; КП-13/20.02.2018 и НСР-14608/08.12.2017; НСР-19252/18.07.2019 |
02.09.2019 |
08.09.2012 |
|
Активен |
1659 |
| C09AA05 |
Ramipril |
Vivace |
Tablet |
5 |
mg |
30 |
Актавис EАД, България |
2.5 |
mg |
- |
4.98 |
0.033 |
1.98 |
25% |
0.49 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-6563/24.06.2015; НСР-10433/29.09.2016 |
02.11.2016 |
08.09.2012 |
|
Активен |
3847 |
| C09AA05 |
Ramipril |
Vivace |
Tablet |
5 |
mg |
30 |
Актавис EАД, България |
2.5 |
mg |
- |
5.18 |
0.02767 |
1.66 |
25% |
0.41 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-2373/21.02.2013 г.; КП-155/29.04.2015. и НСР-3530/16.04.2014; НСР-6530/24.06.2015 |
16.07.2015 |
08.09.2012 |
|
Заличен |
3847 |
| C09AA05 |
Ramipril 100% |
C09AA05 Ramipril 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09AA05 |
Ramipril |
Ampril |
Tablet |
5 |
mg |
30 |
KRKA, d.d., Словения |
2.5 |
mg |
2.74 |
- |
0.02783 |
1.67 |
100% |
1.67 |
|
I10 |
НСР-9219/ 05.05.2016 |
02.08.2019 |
|
|
Активен |
3606 |
| C09AA05 |
Ramipril |
Ampril |
Tablet |
10 |
mg |
30 |
KRKA, d.d., Словения |
2,5 |
mg |
3.34 |
- |
0.02783 |
3.34 |
100% |
3.34 |
|
I10 |
НСР-9218/ 05.05.2016 |
02.08.2019 |
|
|
Активен |
3607 |
| C09AA05 |
Ramipril |
CARDIFRIEND |
Tablet |
5 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
2.5 |
mg |
6.67 |
- |
0.02783 |
1.67 |
100% |
1.67 |
|
I10 |
HCP-8837/13.04.2016; КП-28/26.02.2019 и НСР-17721/10.01.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
994 |
| C09AA05 |
Ramipril |
CARDIFRIEND |
Tablet |
10 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
2.5 |
mg |
13.22 |
- |
0.02783 |
3.34 |
100% |
3.34 |
|
I10 |
HCP-8838/13.04.2016; КП-27/26.02.2019 и НСР-17720/10.01.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
995 |